Searchable abstracts of presentations at key conferences in endocrinology

ea0063p607 | Diabetes, Obesity and Metabolism 2 | ECE2019

Liver fibrosis and steatosis severity evaluation in patients with chronic hepatitis C and type 2 diabetes mellitus

Irina Morozova , Beliy PA , Axelrod AG , Rodnikova EM , Dudina KR , Safiullina NH , Znoyko OO

Background: Non-alcoholic fatty liver disease and chronic hepatitis C (CHC) are systemic diseases with a broad spectrum of coexisting disorders, but their common features are insulin resistance and higher frequency of concomitant type 2 diabetes mellitus (DM). According to recent studies, a higher frequency of CHC in patients with DM is not associated with this cohort exposure to multiple medical interventions, but with CHC being a possible risk factor for developing DM. CHC m...